Pfizer delivered strong 2Q25 results with double-digit revenue growth and margin expansion. Click here to read why PFE stock is a Buy.

The VanEck Pharmaceutical exchange-traded fund is on a strong run this week [as news of Pfizer's deal with the Trump administration]( ...

Dr Philip Mease explores how modern imaging tools are reshaping the understanding of joint damage and progression in psoriatic arthritis.

Pfizer Inc. (NYSE: PFE) made a strong move higher after it became the first drug manufacturer to sign on as part of the TrumpRx platform. PFE stock is up nearly 14% since its closing price of around ...

European shares were set for solid weekly gains on Friday with banks and miners leading early advances as rising Federal Reserve rate-cut bets lifted the STOXX 600 to a record high during the week.

Valneva ( ($VALN) ) has provided an announcement. On October 6, 2025, Valneva SE announced a new $500 million non-dilutive financing agreement ...

Through the FDA's ANDA scheme, drug manufacturers who test and produce their generic medicines on US soil can now seek priority review.

This story was originally published by Grist with the headline In Arizona, a fight against a deadly fungus is under threat from Trump’s health policies on Oct 2, 2025.

Shares of companies that make COVID-19 vaccines sank Friday, after a report raised fears that Trump administration health officials will blame the vaccines for some child deaths. The Washington Post ...

President Trump and members of the cabinet are expected to attend. Federal law enforcement agencies, a new assessment released Thursday, said they are "tracking several threats of unknown credibility" ...